MDS Nordion to partner with Avid Radiopharmaceuticals

Radioisotope developer MDS Nordion of Kanata, Ontario, will collaborate with Avid Radiopharmaceuticals to support clinical studies for the Philadelphia company's radiopharmaceuticals designed to diagnose and monitor Alzheimer's disease.

MDS Nordion will radiolabel Avid's proprietary compounds for use in proof-of-concept clinical trials for SPECT imaging of Alzheimer's disease.

By AuntMinnie.com staff writers
April 4, 2007

Related Reading

MDS Nordion to expand Belgian FDG facility, March 22, 2007

MDS names Prince as CFO, February 20, 2007

MDS Nordion opens European TheraSphere centers, February 8, 2007

MDS Nordion shows Q4 revenue downturn, year-end upturn, December 14, 2006

MDS sells diagnostics unit, October 5, 2006

Copyright © 2007 AuntMinnie.com

Page 1 of 597
Next Page